Bharat Pulse · A TLGS intelligence platform
Policy and regulatory developments for pharmacy networks, e-pharmacy, institutional healthcare and allied operations—with official references and practical implications.
Bharat Pulse · Healthcare regulatory insights
Dated regulatory notes with official references and a separately identified TLGS perspective.
A Maharashtra FDA order brings prescription access and patient choice into the operating controls of hospital-linked pharmacy services.
Official order · reviewed 13 September 2026
Read the sourced insight →Current Maharashtra FDA portal guidance makes application-channel verification an important first step for new manufacturing and sales users.
Official portal guidance · reviewed 13 September 2026
Read the sourced insight →A central-government reply explains the public drug-alert process. For retail and e-pharmacy networks, the operating question is how an alert becomes a traceable, location-specific response.
Official parliamentary reply · reviewed 13 September 2026
Read the sourced insight →These are independent TLGS sector notes, not Tata 1mg statements or findings about a client. Review dates are not announcement dates.
This collection is editorially prepared from the cited public materials. It is not a continuously monitored feed or a representation that all sector developments have been captured. The applicable instrument, amendments and local requirements must be checked for a specific decision.
Specialist practice
Connect licensing, inspection readiness and national operational compliance with the relevant TLGS expertise.
Explore the healthcare regulatory practice →